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BACKGROUND
¡ Glaucoma is a multifactorial progressive optic neuropathy that is characterized by progressive 
neurodegeneration of retinal ganglion cells and their axons
¡ The development of glaucoma has been associated with several factors such as age, family history of 
glaucoma, diabetes, hypertension, and more
¡ Early diagnosis and treatment of glaucoma can significantly delay vision loss if factors associated with 
progression are addressed
PURPOSE
¡ To identify factors potentially associated with glaucomatous progression in 
glaucoma suspect eyes
METHODS
¡ A 5-year longitudinal retrospective study was performed
¡ Optical Coherence Tomography (OCT) parameters included retinal nerve fiber layer thickness (RNFL) of 
the superior, inferior, nasal, temporal, and average regions, cup volume, disc and rim area.
¡ We calculated the percentage of glaucoma suspect eyes that progressed to glaucoma within 5 years




¡ glaucoma suspect eyes (i.e., suspicious cup-to-disc ratio and/or intraocular pressure >21 mm Hg)
¡ age ≥ 30 years old
¡ follow-up time of 5 years 
¡ best-corrected visual acuity 20/100 or better
¡ spherical equivalent better than −8 diopters 
¡ astigmatism less than 3 diopters
Exclusion Criteria
¡ eyes with glaucoma, which was determined by at least 2 consecutive reliable visual field tests
¡ eyes with any significant retinal or neurological disease
RESULTS
¡ A total number of 365 eyes of 288 patients were analyzed (323 eyes with suspicious cup-to-disc ratio 
and 42 eyes with ocular hypertension).
¡ Overall, 55 (15.07%) eyes progressed to glaucoma within average ± SD of 19.12 ± 4.23 months.
¡ Bivariate analysis showed eyes that progressed to glaucoma had significantly thinner average, superior 
and inferior RNFL, and more severe average, superior, and inferior RNFL damages at baseline.
¡ OCT parameters showed no statistically significant difference between the study groups in terms of 
nasal and temporal RNFL thicknesses, cup volume, disc area and rim area at baseline.
¡ Logistic regression analysis showed severe inferior RNFL damage was significantly associated with 5-
year glaucomatous progression
DISCUSSION
¡ In our study, we found eyes in the progressed group have significantly thinner baseline average, superior and 
inferior RNFL thicknesses in bivariate analysis.
¡ However, the logistic regression analysis did not show any significant association between average, superior 
and inferior RNFL thicknesses and 5-year progression of glaucoma
¡ In bivariate analysis, we found that the progressed group had significantly more severe average, superior 
and inferior RNFL damage.
¡ Interestingly, the logistic analysis showed that only severe inferior RNFL damage was significantly associated 
with 5-year glaucomatous damage
¡ In conclusion, we found that severe baseline inferior RNFL damage was significantly associated with 5-year 
glaucomatous progression in glaucoma suspect eyes.
SIGNIFICANCE
¡ Identifying factors related to glaucoma progression early can lead to better patient outcomes
¡ More factors in the future can be tested for and can help us catch glaucoma progression and treat 
accordingly
¡ Patient for example with thinner RNFL at baseline can be treated for future progression of glaucoma sooner 
rather than later
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